Biotech, Small Pharma IPO Market Frozen For At Least Next Year, VCs Say – Bio Korea

OSONG, South Korea - The worldwide market for biotech and other pharmaceutical companies seeking funds through initial public offers is closed for at least a year and other sources of money are becoming scarce as well, venture capital firms said during the annual Bio Korea conference in Osong, South Korea